Tirzepatides dual-action mechanism may make it more effective for some patients, while Semaglutide remains a trusted, proven option with a strong track record
Diabetes Care 33:20742076
Before starting any GLP-1 program in 2026, patients are encouraged to ask their prescribing clinician and the dispensing pharmacy specific questions about dosing, proper storage, potential adverse reactions, drug interactions, current product availability, and whether an FDA-approved medication may be more appropriate for their individual situation
It needs to get into the engine
GLP-1 exposure cases include calls made by people with a suspected poisoning or by people who are experiencing any side effect or symptom after taking the wrong dosage of a medication, or even when they are taking it as prescribed
As little as 3 percent weight loss can have a meaningful benefit for diabetes, hyperglycemia and dyslipidemia (abnormal lipid levels in the bloodstream, which poses a higher risk for cardiovascular disease)but these conditions, along with many others, often require a greater amount of weight loss to lead to health improvements